StockNews.com cut shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a hold rating in a research note ...

Shares of Elevance Health Inc. ELV slipped 1.42% to $405.40 Tuesday, on what proved to be an all-around great trading session ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...

Wall Street Breakfast, Seeking Alpha's flagship daily business news summary, is a one-page summary that gives you a rapid overview of the day's key financial news. It is designed for easy ...

Highlights:,Elevance Health's stock has experienced a dip in value.,The company maintains a moderate debt-to-equity ratio and ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Key earnings reports from Apple, Microsoft, Meta, and Tesla will provide insights into their financial health and future ... it comes to moderation. The Wall Street Journal says executives reached ...

Jan. 27, 2025 — Researchers have uncovered a significant connection between elevated uric acid levels and life-threatening outcomes in children with severe ...